Hepatitis C virus infection in dialysis and renal transplantation.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Kidney International

• Publication date

  1997-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/KI.1997.139PMID 9083262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C infection in cadaver organ donors: strategies to reduce transmission of infection and prevent organ waste

  2004cited by this paper
• Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzymed-linked immunosorbent assay

  2004cited by this paper
• Markers of Hepatitis C Infection among Hemodialysis Patients with Acute and Chronic Infection: Implications for Infection Control Strategies in Hemodialysis Units

  1995cited by this paper
• Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis.

  1995cited by this paper
• Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.

  1995cited by this paper
• Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV.

  1995cited by this paper
• Interferon-alpha 2b treatment of chronic hepatitis C in haemodialysis patients.

  1995cited by this paper
• Report on management of renal failure in Europe, XXIV, 1993.

  1995cited by this paper
• Hepatitis C virus infection among chronic dialysis patients in the southeast of France

  1995cited by this paper
• Hepatitis C virus infection among chronic dialysis patients in the southeast of France. Provence-Alpes-Côte d'Azur Nephrologists Group.

  1995cited by this paper
• High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV.

  1995cited by this paper
• Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant.

  1995cited by this paper
• Is the dialysis membrane a safe barrier against HCV infection?

  1995cited by this paper
• High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies.

  1995cited by this paper
• A controlled study of hepatitis C transmission by organ transplantation

  1995cited by this paper
• Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission.

  1995cited by this paper
• HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis.

  1995cited by this paper
• To C or not to C: these are the questions.

  1995cited by this paper
• Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.

  1995cited by this paper
• A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

  1995cited by this paper
• Prevalence of hepatitis C virus in dialysis patients in Spain

  1995cited by this paper
• Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit.

  1995cited by this paper
• Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.

  1995cited by this paper
• Hepatitis C virus--does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood.

  1995cited by this paper
• Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney.

  1995cited by this paper
• Hepatitis C virus infection in renal transplantation.

  1995cited by this paper
• Hepatitis C virus: the nephrologist's view.

  1995cited by this paper
• The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients.

  1995cited by this paper
• Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).

  1995cited by this paper
• THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION

  1995cited by this paper
• Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C.

  1995cited by this paper
• Recombinant α-interferon in renal allograft recipients with chronic hepatitis C

  1995cited by this paper
• Interferon-α2b treatment of chronic hepatitis C in haemodialysis patients

  1995cited by this paper
• Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients

  1995cited by this paper
• Prevalence of hepatitis C virus in dialysis patients in Spain. Spanish Multicentre Study Group.

  1995cited by this paper
• A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.

  1995cited by this paper
• Transmission of hepatitis C by kidney transplantation--the risks.

  1994cited by this paper
• Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.

  1994cited by this paper
• Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody

  1994cited by this paper
• Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences in viral load.

  1994cited by this paper
• Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan.

  1994cited by this paper
• Hepatitis C serotype and response to interferon therapy.

  1994cited by this paper
• Genotypic analysis of hepatitis C virus in American patients

  1994cited by this paper
• Transmission of hepatitis C virus by organ transplantation in the United Kingdom.

  1994cited by this paper
• Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study.

  1994cited by this paper
• High seroprevalence of hepatitis C infection among risk groups in Egypt.

  1994cited by this paper
• Interferon therapy in renal allograft recipients with chronic hepatitis C.

  1994cited by this paper
• Interferon therapy for chronic viral hepatitis.

  1994cited by this paper
• Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population.

  1994cited by this paper
• Hepatitis C virus‐RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: Evidence for viral replication in peripheral blood mononuclear cells

  1994cited by this paper
• A proposed system for the nomenclature of hepatitis C viral genotypes

  1994cited by this paper
• Interferon therapy of chronic viral hepatitis.

  1994cited by this paper
• Report on management of renal failure in Europe, XXIII.

  1994cited by this paper
• Hepatitis C virus infection in haemodialysis patients: a clinical and virological study.

  1994cited by this paper
• Hepatitis C virus infection in renal dialysis patients in Glasgow.

  1994cited by this paper
• Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam

  1994cited by this paper
• Chromosomal mapping of mouse 5S rRNA genes by direct R-banding fluorescence in situ hybridization.

  1994cited by this paper
• Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a

  1994cited by this paper
• The impact of hepatitis C virus infection on renal allograft recipients.

  1994cited by this paper
• National surveillance of dialysis associated diseases in the United States, 1992.

  1994cited by this paper
• Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study.

  1994cited by this paper
• Horizontal transmission of hepatitis C virus to the spouses of patients on renal replacement therapy.

  1994cited by this paper
• Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand

  1994cited by this paper
• Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children.

  1994cited by this paper
• Mode of nosocomial HCV infection among chronic hemodialysis patients and its prevention

  1994cited by this paper
• Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications

  1994cited by this paper
• Treatment of chronic hepatitis D with interferon alfa-2a.

  1994cited by this paper
• Interferon treatment for chronic hepatitis C virus infection in uremic patients.

  1994cited by this paper
• A Dialysis Case Presentation and Discussion

  1994cited by this paper
• [Incidence and prevalence of anti-HVC antibodies and HBV markers in patients undergoing extracorporeal hemodialysis].

  1994cited by this paper
• A twelve year natural history of hepatitis C virus infection in hemodialyzed patients.

  1994cited by this paper
• Hepatitis C virus infections in dialysis units: prevalence of HCV-RNA and antibodies to HCV.

  1994cited by this paper
• Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

  1993cited by this paper
• Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

  1993cited by this paper
• Donor hepatitis C antibody virus testing in renal transplantation.

  1993cited by this paper
• Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon.

  1993cited by this paper
• Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.

  1993cited by this paper
• Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients.

  1993cited by this paper
• Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection.

  1993cited by this paper
• High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan.

  1993cited by this paper
• Changes in hepatitis C virus antigen in liver with antiviral therapy.

  1993cited by this paper
• Hepatitis C virus infection and organ transplantation.

  1993cited by this paper
• Prevalence of hepatitis C virus infection among long‐term hemodialysis patients: Detection of hepatitis C virus RNA in plasma

  1993cited by this paper
• Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival--a 5- and 10-year follow-up.

  1993cited by this paper
• Hepatitis C virus infection and organ transplantation.

  1993cited by this paper
• Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients.

  1993cited by this paper
• Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities

  1993cited by this paper
• Lack of protective immunity against reinfection with hepatitis C virus.

  1993cited by this paper
• Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis.

  1993cited by this paper
• Transmission of hepatitis C virus by renal transplantation.

  1993cited by this paper
• High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.

  1993cited by this paper
• Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients.

  1993cited by this paper
• Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.

  1993cited by this paper
• Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection

  1993cited by this paper
• Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

  1993cited by this paper
• Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications.

  1993cited by this paper
• Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3

  1993cited by this paper
• National surveillance of hemodialysis associated diseases in the United States, 1990.

  1993cited by this paper
• Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.

  1993cited by this paper
• Use of low-risk HCV-positive donors for kidney transplantation.

  1993cited by this paper

• Anti-hepatitis C virus threshold value in predicting hepatitis C virus viremia in hemodialysis patients

  2025cites this paper
• The transmission risk factors of hepatitis B and C infection in dental treating and tattooing among hemodialysis patients

  2023cites this paper
• Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021

  2022cites this paper
• Therapeutic Advances in Viral Hepatitis A–E

  2022cites this paper
• A Microsimulation Study of the Cost-Effectiveness of Hepatitis C Virus Screening Frequencies in Hemodialysis Centers

  2022cites this paper
• Prevalence of HCV Infection Among Hemodialysis Patients in Lanzhou of Northwestern China

  2022cites this paper
• Performance of rapid test for antibodies to hepatitis C virus (anti-HCV) in hemodialysis patients and kidney transplant recipients

  2022cites this paper
• The efficacy and safety of ombitasvir/paritaprevir/ritonavir plus ribavirin in hepatitis C virus-infected patients with end-stage renal disease on regular hemodialysis

  2021cites this paper
• Management of Hepatitis C in Dialysis Dependent Patients.

  2021cites this paper
• Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran

  2021cites this paper
• HCV and Liver Transplantation

  2021cites this paper
• Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo.

  2021cites this paper
• The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis

  2021cites this paper
• Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population

  2021cites this paper
• Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study

  2020cites this paper
• Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study

  2020cites this paper
• PREVALENCE AND DISTRIBUTION OF HEPATITIS C VIRUS GENOTYPE IN A TERTIARY CARE HOSPITAL IN PUNJAB

  2020cites this paper
• The Seroprevalence of Viral Infections (HCV, HBV, HIV) in Hemodialysis in the Nephrology and Hemodialysis Department of UHC Point G, Bamako (Mali)

  2020cites this paper
• Detection of Hepatis C Virus-Related Immunologic Markers and Their Impact on Outcomes of Living-Donor Kidney Transplant Recipients.

  2019cites this paper
• Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.

  2019cites this paper
• Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population.

  2019cites this paper
• Epidemiological and clinical implications in Kidney Transplantation of occult Hepatitis C virus infection

  2019cites this paper
• Usage of HCV viremic organs in liver transplantation to anti-HCV negative recipients: The current status and review of literature.

  2019influential citation
• Hepatitis C and kidney transplant: The eradication time of the virus has arrived.

  2019cites this paper
• Hepatitis C and kidney transplant: The eradication time of the virus has arrived

  2019cites this paper
• The influence of hemodialysis on FibroTest parameters

  2019cites this paper
• No evidence of occult hepatitis C or E virus infections in liver‐transplant patients with sustained virological response after therapy with direct acting agents

  2019influential citation
• Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

  2019cites this paper
• Frequency of Hepatotropic Viruses Leading To Deranged Liver Function Tests in Renal Transplant Recipients.

  2019cites this paper
• Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

  2019cites this paper
• Hepatitis C virus infection in chronic kidney disease: paradigm shift in management

  2018cites this paper
• Management of Hepatitis C Infection in Kidney Transplantation Candidates and Recipients

  2018cites this paper
• HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?

  2018cites this paper
• Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney

  2018cites this paper
• The Burden of Untreated Hepatitis C Virus Infection in Renal Patients in the United Kingdom

  2018cites this paper
• Utilizing Donors with Hepatitis C Antibody Positivity and Negative Nucleic Acid Testing

  2018cites this paper
• Molecular Epidemiology of Hepatitis C virus in Prishtina region of Kosovo [Molekularna epidemiologija virusa Hepatitisa C u regiji Priština na Kosovu]

  2018influential citation
• Management of Viral Hepatitis in Solid Organ Transplant Recipients.

  2018cites this paper
• Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study

  2017cites this paper
• Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients

  2017cites this paper
• New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment

  2017cites this paper
• New Oral Direct-Acting Antiviral Agents for Treatment of Chronic Hepatitis-C Infection in Patients with Chronic Kidney Disease Including Dialysis Patients and Kidney Transplant Recipients

  2017cites this paper
• Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

  2017cites this paper
• Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up

  2017cites this paper
• Kidney Transplantation in the Hepatitis C Infected Recipient

  2017cites this paper
• Kidney Transplantation in Cirrhotic Patients

  2017cites this paper
• HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs

  2017cites this paper
• Current Concepts in Kidney Transplantation 302 Network for Organ Sharing

  2017cites this paper
• Hepatitis B and C in Kidney Transplantation

  2017cites this paper
• Correlation between Liver Enzymes and Chronic Kidney Disease Iraqi Patients With or Without Hemodialysis

  2017influential citation
• Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia.

  2017cites this paper
• Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End‐Stage Liver Disease Patients

  2017cites this paper
• Occult Hepatitis C Infection Among Hemodialysis Patients: A Prevalence Study.

  2017cites this paper
• Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen

  2017cites this paper
• Importance of Liver Biopsy Findings on Prognosis of Kidney Transplant Patients.

  2016cites this paper
• Regional and Temporal Variations in the Prevalence of HCV among Hemodialysis Patients in Saudi Arabia

  2016cites this paper
• From THE DEPARTMENT OF MEDICINE, SOLNA Karolinska Institutet, Stockholm, Sweden CHRONIC HEPATITIS MORBIDITY AND MORTALITY IN PATIENTS AND THEIR CHILDREN

  2016cites this paper
• Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.

  2016cites this paper
• Hepatitis C y B en pacientes con insuficiencia renal crónica y trasplante renal. Historia natural y decisiones terapéuticas

  2016cites this paper
• [Expert recommendations: Hepatitis C and transplantation].

  2016cites this paper
• DAA‐based antiviral treatment of patients with chronic hepatitis C in the pre‐ and postkidney transplantation setting

  2016cites this paper
• Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach Transplantation

  2016cites this paper
• Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome

  2016cites this paper
• Towards A Successful Peritoneal Dialysis Program

  2016cites this paper
• Ledipasvir and sofosbuvir for treatment of post- renal transplant hepatitis C infection: A case report with review of literature

  2016cites this paper
• Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation.

  2016cites this paper
• Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study

  2016cites this paper
• Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• Hepatitis C infection in hemodialysis patients: A review.

  2015cites this paper
• Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity

  2015cites this paper
• Kidney Transplantation Threshold in Patients With Hepatitis C: A Decision Analysis Model

  2015cites this paper
• Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• Higher Endogenous Erythropoietin Levels in Hemodialysis Patients with Hepatitis C Virus Infection and Effect on Anemia

  2015cites this paper
• Frequency and Risk Factors Associated with Positive Cases of Hepatitis B and Hepatitis C in 100 Dialysis Dependent Patients

  2015cites this paper
• Hepatitis C in hemodialysis patients.

  2015cites this paper
• Hepatitis C and its impact on renal transplantation

  2015cites this paper
• Study on Hepatitis B and Hepatitis C in Haemodialysis patients of National Institute of Kidney Diseases and Urology (NIKDU), Dhaka

  2015cites this paper
• The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.

  2015cites this paper
• Les hémodialysés HVC sont-ils vraiment des patients difficiles à traiter?

  2015cites this paper
• DIAGNOSIS OF HEPATITIS C IN CHRONIC KIDNEY DISEASE AND HEMODIALYSIS Initial testing for HCV

  2015cites this paper
• Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study

  2015cites this paper
• Management of hepatitis C in patients with chronic kidney disease.

  2015cites this paper
• Viral hepatitis C and B among dialysis patients at the Rabat University Hospital: prevalence and risk factors.

  2014cites this paper
• Recurrent HCV after liver transplantation—mechanisms, assessment and therapy

  2014cites this paper
• An archived serum sample as a clue for identifying the primary source of a nosocomial hepatitis C virus outbreak in a haemodialysis unit

  2014cites this paper
• Diabetes Mellitus as a Leading Cause of End-Stage Renal Disease

  2014cites this paper
• Impact of hepatitis C infection on renal transplant patients: a single-center experience in Libya.

  2014cites this paper
• Quiz Page September 2014: Progressive Liver Failure Following Kidney Transplantation

  2014cites this paper
• Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

  2014cites this paper
• Interferon-Based Anti-Viral Therapy for Hepatitis C Virus Infection after Renal Transplantation: An Updated Meta-Analysis

  2014cites this paper
• Hepatitis C recurrence: the Achilles heel of liver transplantation

  2014influential citation
• Liver Disease in Renal Transplant Recipients

  2014cites this paper
• Hepatitis C Infection in Kidney Transplantion

  2013cites this paper
• Epidemiology of dialysis-treated end-stage kidney disease in adults in Libya

  2013cites this paper
• Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience

  2013cites this paper
• Hepatitis C Virus and Nonliver Solid Organ Transplantation

  2013cites this paper
• Hepatitis C virus infection in nephrology patients.

  2013cites this paper
• Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression

  2013cites this paper